These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 25642960)

  • 1. Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination.
    Mateos-Gomez PA; Gong F; Nair N; Miller KM; Lazzerini-Denchi E; Sfeir A
    Nature; 2015 Feb; 518(7538):254-7. PubMed ID: 25642960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
    Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
    Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres.
    Badie S; Carlos AR; Folio C; Okamoto K; Bouwman P; Jonkers J; Tarsounas M
    EMBO J; 2015 Feb; 34(3):410-24. PubMed ID: 25582120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The helicase domain of Polθ counteracts RPA to promote alt-NHEJ.
    Mateos-Gomez PA; Kent T; Deng SK; McDevitt S; Kashkina E; Hoang TM; Pomerantz RT; Sfeir A
    Nat Struct Mol Biol; 2017 Dec; 24(12):1116-1123. PubMed ID: 29058711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
    Doksani Y; de Lange T
    Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for human homologous recombination factors in suppressing microhomology-mediated end joining.
    Ahrabi S; Sarkar S; Pfister SX; Pirovano G; Higgins GS; Porter AC; Humphrey TC
    Nucleic Acids Res; 2016 Jul; 44(12):5743-57. PubMed ID: 27131361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgH class switching and translocations use a robust non-classical end-joining pathway.
    Yan CT; Boboila C; Souza EK; Franco S; Hickernell TR; Murphy M; Gumaste S; Geyer M; Zarrin AA; Manis JP; Rajewsky K; Alt FW
    Nature; 2007 Sep; 449(7161):478-82. PubMed ID: 17713479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
    Somyajit K; Mishra A; Jameei A; Nagaraju G
    Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies: DNA polymerase θ-a new target for synthetic lethality?
    Killock D
    Nat Rev Clin Oncol; 2015 Mar; 12(3):125. PubMed ID: 25687907
    [No Abstract]   [Full Text] [Related]  

  • 12. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection.
    Boersma V; Moatti N; Segura-Bayona S; Peuscher MH; van der Torre J; Wevers BA; Orthwein A; Durocher D; Jacobs JJL
    Nature; 2015 May; 521(7553):537-540. PubMed ID: 25799990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair: Familiar ends with alternative endings.
    Cho NW; Greenberg RA
    Nature; 2015 Feb; 518(7538):174-6. PubMed ID: 25642961
    [No Abstract]   [Full Text] [Related]  

  • 14. Microhomology-mediated end joining: Good, bad and ugly.
    Seol JH; Shim EY; Lee SE
    Mutat Res; 2018 May; 809():81-87. PubMed ID: 28754468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA damage response at dysfunctional telomeres, and at interstitial and subtelomeric DNA double-strand breaks.
    Muraki K; Murnane JP
    Genes Genet Syst; 2018 Jan; 92(3):135-152. PubMed ID: 29162774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations.
    Iliakis G; Murmann T; Soni A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():166-75. PubMed ID: 26520387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining.
    Bergs JW; Krawczyk PM; Borovski T; ten Cate R; Rodermond HM; Stap J; Medema JP; Haveman J; Essers J; van Bree C; Stalpers LJ; Kanaar R; Aten JA; Franken NA
    DNA Repair (Amst); 2013 Jan; 12(1):38-45. PubMed ID: 23237939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
    Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
    Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shelterin-Mediated Telomere Protection.
    de Lange T
    Annu Rev Genet; 2018 Nov; 52():223-247. PubMed ID: 30208292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2.
    Smogorzewska A; Karlseder J; Holtgreve-Grez H; Jauch A; de Lange T
    Curr Biol; 2002 Oct; 12(19):1635-44. PubMed ID: 12361565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.